QuidelOrtho Corporation QDEL EMEA — Cost of sales, excluding amortization of intangibles

Other segment segments

Similar metrics at other companies

COLMEMEA — Cost of Sales

$70.5M+33.4%

ANFEMEA — Cost of Goods and Service, Excluding Depreciation, Depletion, and Amortization

$62.84M-14.6%

INGMEMEA — Cost of Sales

$3.62B+14.2%

PLPCEMEA — Cost of products sold

$24.18M+14.5%

PLXSEMEA — Cost of Sales

$106.43M+10.6%

TTEMEA — Cost of Goods and Service, Excluding Depreciation, Depletion, and Amortization

$462.98M+12.8%

Questions, answered.

What is QuidelOrtho Corporation's EMEA — cost of sales, excluding amortization of intangibles?

QuidelOrtho Corporation (QDEL) reported EMEA — cost of sales, excluding amortization of intangibles of $44.6M in Q1 2026.

How has QuidelOrtho Corporation's EMEA — cost of sales, excluding amortization of intangibles changed year-over-year?

QuidelOrtho Corporation's EMEA — cost of sales, excluding amortization of intangibles decreased by 5.7% year-over-year, from $47.3M to $44.6M.

What is the long-term trend for QuidelOrtho Corporation's EMEA — cost of sales, excluding amortization of intangibles?

Over 3 years (2022 to 2025), QuidelOrtho Corporation's EMEA — cost of sales, excluding amortization of intangibles has grown at a 18.7% compound annual growth rate (CAGR), from $105.1M to $175.9M.

What does EMEA — cost of sales, excluding amortization of intangibles mean?

Measures the direct costs associated with producing and delivering diagnostic products within the EMEA segment, excluding non-cash amortization expenses. This provides a clear view of the operational efficiency and direct margin performance of the regional supply chain.